Common Equity: The sum of all common equity items.
Novo Nordisk A/S (NVO) had Common Equity of $33.54B for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$12.20B |
|
$2.58B |
|
$2.81B |
|
$9.39B |
|
$8.65B |
|
$3.54B |
|
$-242.86M |
|
$3.30B |
|
$3.30B |
|
$2.58B |
|
$2.58B |
|
$2.58B |
|
$2.58B |
|
$3.54B |
|
$5.73B |
|
4.41B |
|
4.42B |
|
$0.59 |
|
$0.58 |
|
| Balance Sheet Financials | |
$32.46B |
|
$37.08B |
|
$59.81B |
|
$92.27B |
|
$38.42B |
|
$18.13B |
|
$20.31B |
|
$58.73B |
|
|
Common Equity |
$33.54B |
$16.33B |
|
$33.54B |
|
-- |
|
| Cash Flow Statement Financials | |
$18.63B |
|
$-6.09B |
|
$-9.79B |
|
$4.08B |
|
$6.80B |
|
$2.72B |
|
-- |
|
$-7.99B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.84 |
|
-- |
|
-- |
|
0.35 |
|
0.62 |
|
76.97% |
|
29.06% |
|
29.06% |
|
-- |
|
27.06% |
|
21.14% |
|
$12.90B |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.36 |
|
0.72 |
|
125.70 |
|
7.69% |
|
15.79% |
|
2.79% |
|
4.99% |
|
-- |
|
$2.92 |
|
$4.22 |
|